Syntocinon: Clinical Trials

113 trials of Syntocinon, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

86 completed, 14 unknown, 6 withdrawn, 3 recruiting. 39 Phase 2, 23 Not applicable, 17 Phase 1, 16 Phase 4, 12 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 239Completed 29, Withdrawn 4, Unknown 3, Terminated 2, Recruiting 1
Not applicable23Completed 17, Unknown 3, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 117Completed 16, Unknown 1
Phase 416Completed 11, Unknown 4, Recruiting 1
Early Phase 112Completed 9, Suspended 1, Unknown 1, Withdrawn 1
Phase 311Completed 10, Unknown 1

Follow Syntocinon: new trials by email Literature Review of Syntocinon trials Research Report on Syntocinon

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Oxytocin Bolus Versus Slow Infusion on Haemodynamic Stability During Caesarean Section Under Spinal Anaesthesia
Oxytocin - Cesarean Section, Hypotension
Not applicableNot yet recruitingKhyber Girls Medical College602026-09-012026-08-25
Carbetocin Monotherapy Versus Carbetocin Plus Oxytocin Infusion in Elective Cesarean Delivery: A Non-Inferiority Trial
Carbetocin, Oxytocin, Placebo Saline Infusion - Postpartum Hemorrhage, Uterine Atony
Phase 4RecruitingMansoura University3322026-08-082026-10-09
Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls
Oxytocin nasal spray, Placebo - Arginine Vasopressin Deficiency, Central Diabetes Insipidus
Phase 2RecruitingUniversity Hospital, Basel, Switzerland422025-07-012025-10-03
Oxytocin and Reward Processing in Women
Intranasal oxytocin administration, Intranasal placebo administration - Menstrual Cycle, Hormonal Contraception
Not applicableRecruitingInternational Research Training Group 28041002024-02-162024-02-28
Oxytocin on Approach Bias and Craving
Oxytocin, Placebo - Alcohol Use Disorder
Phase 2WithdrawnJennifer Mitchell2023-11-012022-06-06
Comparative Study Between Preoperative and Postoperative Rectal Misoprostol
Misoprostol - Blood Loss, Surgical, Blood Loss, Postoperative
Not applicableCompletedEgymedicalpedia1282023-08-312024-08-20
Carbetocin Compared To Oxytocin During Cesarean Delivery
oxytocin, Carbetocin - Cesarean Delivery
UnknownAssiut University2602023-05-012023-03-07
Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor
Oxytocin (Low dose), Oxytocin (High dose) - Labor Long
Phase 4CompletedThe University of Texas Medical Branch, Galveston1702023-04-172026-01-09
Blood Loss During Cesarean Delivery in Placenta Previa Patients
Tranexamic acid, Misoprostol, Oxytocin - Placenta Previa
Phase 4CompletedCairo University812022-05-042023-01-06
Effects of Intranasal Oxytocin in the Treatment of Benzodiazepine Withdrawal: A Pilot RCT
Oxytocin nasal spray, Saline (NaCl 0,9 %) (placebo) - Benzodiazepine Dependence
Phase 2CompletedSt. Olavs Hospital662022-03-012026-09-28
Carbetocin Versus Syntocinon for Prevention of Postpartum Hemorrhage in Cardiac Patients Undergoing Caesarean Section
Syntocinon, Carbetocin - Adverse Effect of Oxytocic Drugs
Phase 4UnknownCairo University382021-11-302023-06-06
Hemostatic Effect of Intrauterine Instillation of Oxytocin in Hysteroscopic Myomectomy
Oxytocin, sterile bacteriostatic water ampule - Leiomyoma
Not applicableCompletedAin Shams Maternity Hospital602021-04-152023-11-07
Prevention of Primary Postpartum Haemorrhage
Misoprostol, Oxytocin - Primary, Post Partum Hemorrhage
Phase 2UnknownIslamabad Medical and Dental College1802021-02-032021-02-25
Induction of Labor in Pregnant Women With Prelabor Rupture of Membranes - Oxytocin or Misoprostol
Misoprostol, Syntocinon - Prelabor Rupture of Membranes
Phase 4CompletedAin Shams Maternity Hospital2002021-02-012022-06-23
A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in Schizophrenia
Oxytocin, Placebo - Schizophrenia
Phase 2TerminatedVA Office of Research and Development262020-01-132026-01-20
Oxytocin Treatment for Alcohol Use Disorders
Oxytocin, Placebo - Alcohol Use Disorder
Phase 2WithdrawnUniversity of North Carolina, Chapel Hill2019-10-012019-11-13
Inhaled Oxytocin and HPA Axis Reactivity
Intranasal Oxytocin, Placebo - Depression, Postpartum, Anxiety Disorders
Phase 2CompletedUniversity of North Carolina, Chapel Hill1092019-02-072025-08-08
Intranasal Oxytocin and Food Intake in Obese Adolescents
Syntocinon, Placebo - Obesity
Phase 2WithdrawnShana McCormack, MD2018-09-012018-12-26
Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome
Intranasal Oxytocin (IN-OXT), Matched Placebo - Prader-Willi Syndrome, Hyperphagia
Phase 2CompletedEric Hollander322018-04-112025-02-07
Intranasal Oxytocin for Frontotemporal Dementia
Syntocinon - Frontotemporal Dementia
Phase 2UnknownLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1122018-01-312023-12-15

Showing 20 of 113. Sign in to see all of them.

Conditions studied

Autism Spectrum Disorder (11)  ·  Postpartum Hemorrhage (11)  ·  Schizophrenia (9)  ·  Autistic Disorder (7)  ·  Alcoholism (6)  ·  Anxiety Disorders (5)  ·  Obesity (5)  ·  Prader-Willi Syndrome (5)  ·  Diabetes Insipidus (4)  ·  Stress Disorders, Post-Traumatic (4)  ·  Substance-Related Disorders (4)  ·  Depression, Postpartum (3)  ·  Frontotemporal Dementia (3)  ·  Hemorrhage (3)  ·  Blood Loss, Surgical (2)

Sponsors

University of California, San Francisco (9)  ·  Massachusetts General Hospital (8)  ·  Ain Shams Maternity Hospital (4)  ·  University of North Carolina, Chapel Hill (4)  ·  Ain Shams University (3)  ·  Cairo University (3)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (3)  ·  University Hospital, Bonn (3)  ·  Alexander Kolevzon (2)  ·  Emory University (2)  ·  Evdokia Anagnostou (2)  ·  Holland Bloorview Kids Rehabilitation Hospital (2)  ·  KU Leuven (2)  ·  Norwegian University of Science and Technology (2)  ·  Shana McCormack, MD (2)

Countries

United States (56)  ·  Egypt (13)  ·  Canada (10)  ·  Germany (4)  ·  Israel (4)  ·  Norway (4)  ·  Australia (2)  ·  Belgium (2)  ·  Pakistan (2)  ·  Sweden (2)  ·  Brazil (1)  ·  China (1)  ·  Denmark (1)  ·  France (1)  ·  Iran (1)

Top investigators

Josh D Woolley, MD/PhD (5)  ·  Evdokia Anagnostou, M.D. (3)  ·  David Mankuta, MD (2)  ·  Eric Hollander, MD (2)  ·  Gagan Joshi, MD (2)  ·  Kaat Alaerts, PhD (2)  ·  Lane Strathearn, MBBS PhD (2)  ·  Olav Spigset, MD PhD (2)  ·  Suma Jacob, M.D., Ph.D. (2)  ·  Alexander Kolevzon, MD (1)  ·  Alison M Stuebe, MD, MSc (1)  ·  Allan L Reiss (1)  ·  Allen Song, PhD (1)  ·  Amanda Wang, MD (1)  ·  Annie Dupuis, Ph.D. (1)

Results publications

PMID 37811711, PMID 15931222, PMID 21862226, PMID 23216716, PMID 24734184, PMID 25224026, PMID 26994593, PMID 27137199, PMID 27314560, PMID 27350226, PMID 28416501, PMID 30189345, PMID 30261917, PMID 30606246, PMID 30784955, PMID 30791944, PMID 31477047, PMID 32053696, PMID 32963103, PMID 33112417, PMID 33543897, PMID 33587397, PMID 33853878, PMID 34593045, PMID 34697392, PMID 35141873, PMID 35358738, PMID 36239406, PMID 37442883, PMID 37883133, PMID 38445382, PMID 38767196, PMID 38815173, PMID 39862881, PMID 42714565

NIH funding

2015 (2), 1IK2CX001495-01 (1), 2004 (1), 2014 (1), 2019 (1), I01CX001761 (1), P50DA016511 (1), P50MH082999 (1), P50MH100023 (1), R01AA025942 (1), R01HD093901 (1), R01NR012899 (1), R21HD078778 (1), R21HD090396 (1), U54HD079124 (1)